{"id":6181,"date":"2022-03-10T14:16:59","date_gmt":"2022-03-10T13:16:59","guid":{"rendered":"https:\/\/services.cbmed.at\/html\/old\/?page_id=6181"},"modified":"2024-02-07T13:55:29","modified_gmt":"2024-02-07T12:55:29","slug":"precision-medicine-technologies","status":"publish","type":"page","link":"https:\/\/services.cbmed.at\/html\/old\/?page_id=6181","title":{"rendered":"Precision Medicine Technologies"},"content":{"rendered":"
<\/div><\/div>
<\/div><\/div><\/main><\/div><\/div>
\n
<\/div><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div>
\n
<\/div>

Within the research area “Precision Medicine Technologies”, advanced technologies within our Core Labs and Services, on the one hand, and IT-driven approaches, on the other, strengthen the link between all CBmed projects. A special focus is therefore data integration and interactive knowledge discovery, based on the fact that biomarker discovery and validation result in a vast amount of heterogeneous, high-dimensional, weakly structured and complex data sets.<\/p>\n<\/div><\/section><\/div>

<\/div>\n\n<\/div><\/div><\/div><\/div><\/div>
\n
<\/div>
<\/div>

Cutting-edge technologies offer high quality analyses on a multi-platform level and a comprehensive approach to biomarker discovery combining the complementary advantages of targeted and untargeted methods. Multi-layered data from all of these technologies are produced by their repeated application in Cancer Research for Precision Medicine<\/a> and Microbiome Research for Precision Medicine<\/a>, producing a vast amount of data which is integrated in CBmed\u2018s inhouse IT-infrastructure, including, specialised biostatistical and bioinformatic analyses and interpretation.<\/p>\n<\/div><\/section><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/div>

\n
<\/div>\n

Combining FUSION technology with digital biomarkers for a more comprehensive approach in biomarker research.<\/h3>\n<\/div><\/section><\/div>
<\/div><\/p>\n
<\/a><\/div><\/div><\/div><\/div>\n